Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
---|---|---|---|
USD 47.17 Billion | USD 91.97 Billion | 7.7% | 2024 |
FrequentlyAsked Questions
The global injection pen market is expected to grow due to increasing adoption of self-administration drug delivery devices, rising prevalence of diabetes and chronic diseases, and technological advancements in pen injectors.
According to a study, the global injection pen market size was worth around USD 47.17 Billion in 2024 and is expected to reach USD 91.97 Billion by 2034.
The global injection pen market is expected to grow at a CAGR of 7.7% during the forecast period.
North America is expected to dominate the injection pen market over the forecast period.
Leading players in the global injection pen market include Eli Lilly and Company, Sanofi, Becton, Dickinson and Company, Ypsomed Holding AG, Novo Nordisk A/S, Sun Pharmaceutical Industries Ltd., Pfizer, AstraZeneca plc, F. Hoffmann-La Roche Ltd., and Merck KGaA, among others.
The report explores crucial aspects of the injection pen market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed